Lineage Cell Therapeutics, Inc. ($LCTX)
Filing Information
| Accession Number | 0001193125-26-052021 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 14, 2026 |
| Document Date | Feb 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
75,369
Total Value
$23,164.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Feb 11, 2026 | Exercise/Conversion | 31,250 | โ | โ | 253,385 | Direct | โ | View Details | |
Director | Common Shares | โ | Feb 11, 2026 | Tax Withholding | 12,869 | $1.80 | $23,164.20 | 240,516 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Feb 11, 2026 | Exercise/Conversion | 31,250 | $0.00 | $0.00 | 0 | Direct | โ | View Details |